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Physiological cardiac hypertrophy is associ-
ated with mitochondrial adaptations that are
characterized by activation of PGC-1a and
increased fatty acid oxidative (FAO) capacity.
It is widely accepted that phosphatidylinositol
3-kinase (PI3K) signaling to Akt1 is required
for physiological cardiac growth. However, the
signaling pathways that coordinate physiologi-
cal hypertrophy and metabolic remodeling are
incompletely understood. We show here that
activation of PI3K is sufficient to increase
myocardial FAO capacity and that inhibition of
PI3K signaling prevents mitochondrial adapta-
tions in response to physiological hypertrophic
stimuli despite increased expression of PGC-
1a. We also show that activation of the down-
stream kinase Akt is not required for the mito-
chondrial adaptations that are secondary to
PI3K activation. Thus, in physiological cardiac
growth, PI3K is an integrator of cellular growth
and metabolic remodeling. Although PI3K sig-
naling to Akt1 is required for cellular growth,
Akt-independent pathways mediate the accom-
panying mitochondrial adaptations.
INTRODUCTION
Cardiac hypertrophy has classically been categorized as
‘‘physiological’’ as occurs during development or in re-
sponse to exercise training and ‘‘pathological’’ as occurs
following pressure overload. Physiological hypertrophy
is a compensated state with preserved or enhanced func-
tion over time, whereas pathological hypertrophy often294 Cell Metabolism 6, 294–306, October 2007 ª2007 Elsevierprogresses to heart failure. The functional consequences
of cardiac hypertrophy may be due to differences in sig-
naling pathways that contribute to pathological versus
physiological cardiac growth (Dorn and Force, 2005).
Cardiac hypertrophy can dramatically alter myocardial
substrate metabolism depending on the stimulus for
hypertrophy. The metabolic flexibility of the heart allows
it to maintain energy needs in response to various signals
for growth, and disruption of this flexibility can impair func-
tion (Ritchie and Delbridge, 2006). Physiological hypertro-
phy (during maturation from birth to adulthood or following
exercise training) is associated with mitochondrial biogen-
esis and an increased capacity to oxidize fatty acids (FAs)
and glucose (Burelle et al., 2004; Lehman et al., 2000).
Pathological hypertrophy, which increases the risk for
developing heart failure, is associated with reduced FA
metabolism and increased dependence on glucose utili-
zation (Allard et al., 1994; Arany et al., 2006; Massie
et al., 1995).
Isoforms of peroxisome proliferator-activated receptors
(PPARs) and PPARg coactivator-1 (PGC-1) are key tran-
scriptional regulators of cardiac metabolism (Huss and
Kelly, 2005). PPARa is a ligand-activated nuclear receptor
involved in transcription of many FA oxidation genes. The
transcriptional coactivators PGC-1a and PGC-1b serve
as important regulators of mitochondrial remodeling in
the heart by coactivating PPARs and nuclear respiratory
factors 1 and 2 (NRF1/2) to coordinately increase mito-
chondrial biogenesis and oxidative capacity (Huss et al.,
2002; Lehman et al., 2000; Russell et al., 2004; Vega
et al., 2000). However, the signaling pathways that coor-
dinate the mitochondrial adaptations in the context of
cardiac hypertrophy are not fully understood.
It is widely accepted that phosphatidylinositol 3-kinase
(PI3K) signaling to Akt is an important regulator of cellular
and organ growth. Class IA PI3Ks consist of a p110a
catalytic subunit and a p85/p55 regulatory subunit, which
can be activated by growth factors to phosphorylateInc.
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PI3K and Mitochondria in Cardiac Hypertrophyphosphatidylinositol-4,5-bisphosphate at the 3 position to
produce phosphatidylinositol-3,4,5-triphosphate (PIP3).
PIP3 initiates activation of downstream targets, such as
phosphatidylinositol-dependent kinase 1 (PDK1) and Akt,
that modulate a wide variety of cellular processes includ-
ing metabolism, cell growth, protein synthesis, and gene
transcription. In the heart, activation of p110a induces
compensated hypertrophy, whereas inhibition of PI3K
results in a reduction in cardiac size (Luo et al., 2005;
Shioi et al., 2000). p110a signaling is necessary for phys-
iological cardiac growth in response to exercise training
but is dispensable for pathological hypertrophy (Luo et al.,
2005; McMullen et al., 2003).
Akt1 and Akt2 are the most abundant Akt isoforms in
the heart. Akt1 is required for physiological hypertrophy
in response to exercise training and IGF-1 stimulation
(DeBosch et al., 2006). Transgenic overexpression of Akt
isoforms in the heart results in a greater degree of cardiac
hypertrophy, with a broad spectrum of functional conse-
quences from increased contractility to decreased ejec-
tion fraction and heart failure, which may depend in part
on the degree of Akt overexpression (Condorelli et al.,
2002; Matsui et al., 2001; Shioi et al., 2002). It is currently
unknown whether activation of PI3K and/or activation of
Akt signaling play any role in the metabolic remodeling
that accompanies physiological cardiac growth.
The aim of the current study was to determine the role of
myocardial PI3K/Akt signaling in the metabolic and mito-
chondrial adaptations that occur in the context of physio-
logical cardiac hypertrophy. By examining various mouse
mutants with activation or inhibition of PI3K and Akt
signaling, we show that PI3K signaling coordinately regu-
lates physiological cardiac growth and the associated
mitochondrial adaptations. In contrast to most other meta-
bolic effects of PI3K signaling, these changes are inde-
pendent of Akt activation.
RESULTS
PI3K Increases Cardiac Fatty Acid Oxidative
Capacity
To determine whether activation of PI3K in the heart
increases mitochondrial oxidative capacity, we mea-
sured substrate metabolism and mitochondrial function
in hearts from mice with cardiac-restricted constitutive
activation of PI3K (caPI3K). These mice have cardiac hy-
pertrophy (20%) with preserved function (Shioi et al.,
2000). Relative to controls, phosphorylation of Akt and
its downstream targets is increased in caPI3K hearts
(Figure 1A). Palmitate oxidation, glycolysis, and glucose
oxidation in perfused working hearts from 5- to 7-week-
old caPI3K mice were increased (Figures 1B–1D), and
indices of cardiac function in isolated working hearts,
including left ventricular developed pressure and cardiac
output, were modestly increased in caPI3K mice relative
to controls (see Table S1 in the Supplemental Data
available with this article online). Mitochondrial respira-
tion and ATP production in permeabilized cardiac fibers
from caPI3K mice were unchanged when using eitherCell Mglutamate or pyruvate as a substrate (Figure 1E and data
not shown), but the maximal rate of mitochondrial respira-
tion (state 3) using palmitoylcarnitine (PC) as a substrate
was increased in caPI3K cardiac fibers compared to
controls (Figure 1F). Despite a significant increase in
state 4 of mitochondrial respiration (in the presence of
oligomycin), ATP synthesis rates and the ATP/O ratio
(the amount of ATP produced per molecule of oxygen
consumed) were unchanged relative to controls, sug-
gesting that mitochondrial oxygen consumption was tightly
coupled to ATP production in caPI3K hearts (Figure 1G
and data not shown). Activity of 3-hydroxyacyl-CoA
dehydrogenase (HADH), a key enzyme in b-oxidation,
and citrate synthase (CS), a rate-limiting step in the citric
acid cycle, was increased in caPI3K cardiac tissue (Fig-
ures 1H and 1I). Increased mitochondrial enzymatic activ-
ity, particularly CS activity, could suggest changes in
mitochondrial number or morphology. Electron micro-
scopic studies indicated that cardiac structure, mitochon-
drial number, and mitochondrial morphology were un-
changed in caPI3K hearts compared to controls (Figure
S1). Additionally, mitochondrial DNA content was also
unchanged in caPI3K hearts. When normalized to mito-
chondrial protein, CS activity measured in isolated mito-
chondria from caPI3K hearts was increased (Figure 1J),
indicating that the increased mitochondrial enzymatic
activity is likely due to increased enzymatic activity per
mitochondrion rather than changes in mitochondrial
number.
PI3K Inhibition Reduces Cardiac
Fatty Acid Oxidation
We next determined the effect of inhibition of PI3K sig-
naling on mitochondrial oxidative capacity using mice
with cardiac-restricted expression of a dominant-negative
p110a (dnPI3K). Hearts from dnPI3K mice are significantly
smaller than control hearts but maintain function in vivo
(Shioi et al., 2000). Mitochondrial respiration and ATP
production in saponin-permeabilized cardiac fibers from
5- to 7-week-old dnPI3K hearts were unchanged relative
to controls using either glutamate or pyruvate as substrate
(Figure 2A and data not shown). However, state 3 of respi-
ration and ATP production were significantly reduced in
dnPI3K fibers treated with PC as substrate (Figures 2B
and 2C). Reduced PC respiration was correlated with
decreased palmitate oxidation, cardiac power, and car-
diac output in isolated working hearts from older dnPI3K
mice (Figure S2). Enzymatic activity of HADH and CS
was significantly reduced in heart homogenates from
dnPI3K mice (Figures 2D and 2E). However, electron
microscopy of cardiac tissue revealed no changes in car-
diac structure, mitochondrial number, or mitochondrial
morphology (Figure S3).
PI3K Signaling and Cardiac Response
to Exercise Training
To determine whether PI3K signaling is required for the
cardiac mitochondrial adaptations to physiological hyper-
trophy, we exposed 8- to 10-week-old dnPI3K and controletabolism 6, 294–306, October 2007 ª2007 Elsevier Inc. 295
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PI3K and Mitochondria in Cardiac HypertrophyFigure 1. Activation of PI3K Increases
Mitochondrial Fatty Acid Metabolism in
the Heart
(A) Phosphorylation of PI3K and Akt targets in
caPI3K hearts.
(B–D) Palmitate oxidation (B), glycolysis (C),
and glucose oxidation (D) in isolated working
hearts from 5- to 7-week-old caPI3K and con-
trol mice. In this and all subsequent figures,
error bars represent SEM.
(E and F) Mitochondrial respiration rates in sa-
ponin-permeabilized cardiac fibers exposed to
5 mM glutamate/2 mM malate (E) or 20 mM
palmitoylcarnitine (PC)/5 mM malate (F) as
substrate. RC, respiratory control ratio (state
3/state 4).
(G) ATP synthesis rates with PC in cardiac
fibers.
(H and I) 3-hydroxyacyl-CoA dehydrogenase
(HADH) (H) and citrate synthase (CS) (I) enzy-
matic activity rates in whole heart homoge-
nates.
(J) CS activity in isolated mitochondria from
caPI3K and control mice.
n = 4–8 per group; *p < 0.05, **p < 0.01 versus
wild-type (WT).mice to 3 weeks of swimming exercise training. In previ-
ous studies, inhibition of PI3K signaling in dnPI3K mice
prevented exercise-induced cardiac hypertrophy but had
no effect on cardiac function measured by echocardio-
graphy (McMullen et al., 2003). We measured phosphor-
ylation levels of Akt and its downstream targets in hearts
from exercise-trained and sedentary mice (Figure 3A).
Densitometric analysis showed that phosphorylation ra-
tios of Akt and FoxO1 were significantly attenuated in re-
sponse to exercise training in dnPI3K hearts compared to
controls (Figure 3B). Swim-trained wild-type (WT) mice
exhibited robust cardiac hypertrophy, but hypertrophy in
swim-trained dnPI3K mice was prevented (Figure 3C)
despite similar degrees of exercise training as evidenced
by equivalent increases in CS activity in skeletal muscle
of exercise-trained dnPI3K and WT mice (Figure S4).
Swim-trained WT mice showed enhanced mitochondrial
respiration and ATP production with PC as substrate com-
pared to sedentary controls (Figures 3D and 3E). Consis-
tent with observations in younger animals, 11- to 13-
week-old dnPI3K sedentary mice show decreased state
3 of respiration compared to WT sedentary controls.
Swimming training did not increase mitochondrial respira-296 Cell Metabolism 6, 294–306, October 2007 ª2007 Elsevier Ition or ATP synthesis rates in dnPI3K hearts (Figures 3D
and 3E).
PI3K and Transcript Levels of Cardiac
Metabolic Enzymes
To investigate whether PI3K-mediated changes in mito-
chondrial fatty acid oxidative (FAO) capacity reflect
transcriptional changes, we determined mRNA levels of
FAO enzymes and oxidative phosphorylation (OXPHOS)
subunits by quantitative real-time PCR in caPI3K and
dnPI3K hearts. Although medium-chain acyl-CoA de-
hydrogenase (MCAD) transcript levels were increased
in caPI3K hearts, FAO enzyme and OXPHOS subunit
mRNA levels remained largely unchanged (Figure 4A). In
contrast, mRNA levels of MCAD, long-chain acyl-CoA
dehydrogenase (LCAD), very long-chain acyl-CoA dehy-
drogenase (VLCAD), muscle carnitine palmitoyltransfer-
ase 1 (CPT1b), carnitine palmitoyltransferase 2 (CPT2),
HADH a and b subunits (Hadha andHadhb), and a subunit
of complex III (Uqcrc1) were reduced in dnPI3K hearts
from 5- to 7-week-old female mice compared to controls
(Figure 4B). In hearts from 11- to 13-week-old WT male
mice, swimming exercise training induced increases innc.
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Mitochondrial Fatty Acid Metabolism in
the Heart
(A and B) Mitochondrial respiration rates in
saponin-permeabilized cardiac fibers from
5- to 7-week-old dnPI3K and control mice
exposed to glutamate/malate (A) or PC (B) as
substrate.
(C) ATP synthesis rates with PC in cardiac
fibers.
(D and E) HADH (D) and CS (E) activity rates in
whole heart homogenates.
n = 5–8 per group; *p < 0.05, **p < 0.01 versus
WT.mRNA levels of MCAD, a subunit of complex I (Ndufa9),
and a subunit of complex IV (Cox4i1) compared to seden-
tary controls (Figure 4C). Hearts from exercise-trained
dnPI3K mice did not evidence increased mRNA levels of
MCAD compared to sedentary controls, and the exer-
cise-induced increase in Cox4i1 mRNA levels was attenu-
ated (Figure 4C).
We also determined mRNA expression of PPARa, PGC-
1 isoforms, and estrogen-related receptor a (ERRa), which
are transcriptional regulators of FAO and OXPHOS genes
(Huss and Kelly, 2004). No changes in mRNA levels of
PPARa, PGC-1b, or ERRa were observed in caPI3K
hearts, but mRNA levels of PGC-1a were decreased com-
pared to controls (Figure 5A). No changes in mRNA levels
of PPARa, PGC-1b, or ERRa were observed in dnPI3K
hearts (Figure 5B). Despite downregulation of FAO and
OXPHOS genes in dnPI3K hearts, mRNA levels of PGC-
1a were increased 1.23-fold compared to controls
(Figure 5B). Although exercise training induced PPARa
mRNA levels in WT hearts compared to WT sedentary
controls, PPARa mRNA levels were unchanged in exer-
cise-trained dnPI3K hearts relative to exercise-trained
WT hearts or dnPI3K sedentary controls (Figure 5C).
PGC-1a mRNA levels were induced by exercise training
in WT mice. Despite reduced mitochondrial respiration,
hearts from both sedentary and exercise-trained dnPI3K
mice showed increases in PGC-1a mRNA expression
levels similar to those observed in exercise-trained WT
mice (Figure 5C). No changes were observed in PGC-1b
mRNA levels in hearts from exercise-trained or sedentary
WT or dnPI3K mice. Western analysis of nuclear-enriched
fractions of cardiac tissue confirmed that protein expres-
sion of PGC-1a was significantly decreased in caPI3K
hearts relative to controls (Figure 5D; densitometric ratio
of PGC-1a to the nonspecific band: WT = 1.21 ± 0.04,
caPI3K = 0.83 ± 0.10; p < 0.05). Conversely, relative to
sedentary controls, PGC-1a protein expression was in-Cell Mcreased in both exercise-trained WT hearts and sedentary
dnPI3K hearts (Figure 5D).
Activated Akt Reduces Cardiac Fatty
Acid Metabolism
To determine whether Akt mediates the effects of PI3K on
myocardial mitochondrial FAO capacity, we determined
mitochondrial function in hearts of mice with cardiac-re-
stricted expression of a constitutively active Akt1 mutant
(T308D/S473D) (caAkt). Hearts from 2-week-old caAkt
mice exhibit robust hypertrophy with preserved cardiac
function that progressively declines by 14 weeks of age,
and heart failure ensues by 20 weeks of age (Shioi et al.,
2002). To avoid the confounding effects of heart failure
on the mitochondrial phenotype of caAkt hearts, we stud-
ied mice between 5 and 7 weeks of age. States 2 and 3 of
mitochondrial respiration with PC as substrate were de-
creased in caAkt cardiac fibers compared to controls
(Figure 6A). Rates of ATP synthesis were also reduced in
caAkt fibers (Figure 6B) to a degree similar to that of
dnPI3K hearts at the same age. Enzymatic activity of
HADH and CS was markedly reduced in heart homoge-
nates from caAkt mice relative to controls (Figures 6C
and 6D). When normalized to mitochondrial protein, CS
activity in mitochondria isolated from caAkt hearts was
also reduced, suggesting diminished enzymatic activity
per mitochondrion (Figure 6E).
Akt Isoforms and Cardiac Exercise Adaptation
We next determined mitochondrial function in sedentary
or exercise-trained mice with either germline deletion of
Akt1 or Akt2 or cardiac-restricted expression of a ki-
nase-deficient Akt1 mutant (K197M) (kdAkt) (Shioi et al.,
2002) to evaluate whether mitochondrial adaptations
to exercise-induced cardiac hypertrophy require the
activity of a specific Akt isoform. Akt1/ mice are char-
acterized by decreased body size and normal glucoseetabolism 6, 294–306, October 2007 ª2007 Elsevier Inc. 297
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Cardiac Hypertrophy and Mitochondrial
Adaptations in Response to Exercise
Training
(A and B) Western blot analysis (A) and densito-
metric ratios (B) of phosphorylated targets of
PI3K and Akt in hearts from wild-type seden-
tary (WT sed), wild-type exercise-trained (WT
ex), dnPI3K sedentary (dnPI3K sed), and
dnPI3K exercise-trained (dnPI3K ex) mice.
(C) Heart weight to body weight (HW/BW) ratio
in exercise-trained dnPI3K and control mice.
(D and E) Mitochondrial respiration (D) and ATP
synthesis (E) with PC in cardiac fibers from WT
and dnPI3K sedentary and exercise-trained
mice.
n = 4–6 per group; *p < 0.05, **p < 0.01 versus
WT sed.tolerance, whereas Akt2/ mice exhibit impaired glucose
tolerance and hepatic insulin resistance (Chen et al.,
2001; Cho et al., 2001a, 2001b; Garofalo et al., 2003).
Cardiac function and dimensions as measured by echo-
cardiography were not significantly different between
Akt1/, Akt2/, and control mice and were unchanged
between sedentary and exercise-trained mice (Table S2).
Exercise increased phosphorylation of Akt in hearts
from control animals for each group (Figure 6F). Phos-
phorylation of residual Akt isoforms increased with
exercise training in Akt1/ hearts, whereas phosphoryla-
tion levels of the residual Akt isoforms in Akt2/ hearts
was variable and did not globally increase with exercise
training (Figure 6F). Hearts from kdAkt mice overexpressed
an Akt isoform that could still be phosphorylated, and
exercise training increased its phosphorylation (Figure
6F). State 3 of respiration with PC as substrate was
unchanged in cardiac fibers from sedentary Akt1/,
Akt2/, and kdAkt mice relative to WT controls (Figure
6G). Additionally, mitochondrial respiration with PC
was increased in cardiac fibers from exercise-trained
Akt1/, Akt2/, kdAkt, and control mice compared to
sedentary mice of the same genotype (Figure 6G). Cardiac
hypertrophy as measured by heart weight to tibia length
ratio was increased in exercise-trained Akt2/ and298 Cell Metabolism 6, 294–306, October 2007 ª2007 Elseviercontrol mice but was prevented in exercise-trained
Akt1/ mice and was not significantly increased in exer-
cise-trained kdAkt mice (Figure 6H). The same degree of
exercise training was achieved in Akt1/, Akt2/, kdAkt,
and control mice as evidenced by increased CS activity in
mixed gastrocnemius muscle from exercise-trained mice
relative to sedentary mice of the same genotype
(Figure 6I). Thus, whereas Akt1 is required for physiologi-
cal cardiac hypertrophy, it does not mediate the mito-
chondrial adaptations that accompany exercise training.
Moreover, the studies in Akt2/ hearts, in which mito-
chondrial respiration increased despite variable phos-
phorylation of residual Akt isoforms with exercise and
a preserved mitochondrial response to exercise in kdAkt
hearts, provide additional evidence for the absence of
a role for Akt in mediating the metabolic adaptations to
exercise-induced cardiac hypertrophy.
Akt Inhibition in caPI3K Hearts
Attenuates Hypertrophy
Given the deleterious effects of Akt overexpression on
mitochondrial oxidative capacity and the absence of any
impact of germline Akt deletion on mitochondrial function,
we hypothesized that PI3K regulates FAO capacity in the
heart independently of Akt signaling. To address thisInc.
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PI3K and Mitochondria in Cardiac HypertrophyFigure 4. mRNA Quantification of Fatty
Acid Oxidation Enzymes and Oxidative
Phosphorylation Complex Subunits in
caPI3K and dnPI3K Hearts
(A) mRNA levels in hearts from caPI3K mice.
n = 8 per group.
(B) mRNA levels in hearts from dnPI3K mice.
n = 12 per group.
(C) mRNA levels expressed as fold change
versus sedentary WT in hearts from 12-week-
old exercise-trained WT, sedentary dnPI3K,
and exercise-trained dnPI3K mice. n = 4–6
per group.
Data are expressed as fold change versus WT.
*p < 0.05, **p < 0.01 versus WT or WT sed.
MCAD, medium-chain acyl-CoA dehydroge-
nase; LCAD, long-chain acyl-CoA dehydroge-
nase; VLCAD, very long-chain acyl-CoA
dehydrogenase; CPT1b, carnitine palmitoyl-
transferase 1 muscle isoform; CPT2, carnitine
palmitoyltransferase 2; Hadha/b, 3-hydrox-
yacyl-CoA dehydrogenase a/b subunits;
Ndufa9, NADH dehydrogenase (ubiquinone)
1a subcomplex 9; Ndufv1, NADH dehydroge-
nase (ubiquinone) flavoprotein 1;Uqcrc1, ubiq-
uinol-cytochrome c reductase core protein 1;
Cox4i1, cytochrome c oxidase subunit IV
isoform 1; Cox5b, cytochrome c oxidase sub-
unit Vb.question, we performed an epistatic experiment by cross-
ing caPI3K mice to kdAkt mice to produce double-trans-
genic (DTG) mice. No differences were observed in body
weights of DTG mice compared to single-transgenic or
WT controls. Heart weight to body weight (HW/BW) ratios
were not different between kdAkt and WT mice (Figure 7A).
The HW/BW ratio was increased relative to WT in caPI3K
mice (1.21 ± 0.01 fold), and this hypertrophy was signifi-
cantly attenuated in DTG mice (1.12 ± 0.01 fold, p < 0.01
versus caPI3K; Figure 7A), recapitulating previously pub-
lished observations (Shioi et al., 2002). Western analysis
of heart homogenates revealed that phosphorylation of
multiple downstream targets of Akt was significantly in-
creased in caPI3K hearts (Figure 7B). The increases in
phosphorylation of Akt targets were blocked in hearts
from DTG mice, indicating that signaling downstream of
Akt is significantly attenuated in DTG hearts (Figure 7B).
State 3 of mitochondrial respiration with PC as sub-
strate was unchanged in cardiac fibers from kdAkt mice
compared to WT controls (Figure 7C). As previously ob-
served, caPI3K cardiac fibers showed enhanced state 3
of respiration (1.13 ± 0.04 fold increase over WT) withCell MPC as substrate, and this enhancement was not attenu-
ated in DTG mice (1.15 ± 0.05 fold increase over WT)
(Figure 7C). Interestingly, ATP synthesis rates with PC
were increased in cardiac fibers from kdAkt mice com-
pared to WT controls (Figure 7D). Again, ATP production
was unchanged in caPI3K cardiac fibers with PC com-
pared to WT, but synthesis rates remained increased in
DTG fibers (Figure 7D).
HADH activity was significantly increased in DTG hearts
compared to WT, to a degree similar to caPI3K (Figures
7E). CS activity was also significantly increased in kdAkt,
caPI3K, and DTG hearts (Figure 7F).
Inhibition of PKCl/z Signaling and Cardiomyocyte
Citrate Synthase
To begin to elucidate possible alternative signaling path-
ways that contribute to PI3K-mediated mitochondrial
remodeling, we treated neonatal rat cardiomyocytes
(NRCMs) with insulin and IGF-1 in the presence of Akt or
PKCl/z inhibitors and assessed CS activity. Insulin and
IGF-1 treatment for 72 hr was sufficient to increase activity
of Akt and PKCl/z signaling as evidenced by increasedetabolism 6, 294–306, October 2007 ª2007 Elsevier Inc. 299
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PI3K and Mitochondria in Cardiac HypertrophyFigure 5. Expression of Transcriptional
Regulators of Fatty Acid Oxidation
Enzymes and Oxidative Phosphorylation
Complex Subunits in caPI3K and dnPI3K
Hearts
(A) mRNA levels in hearts from caPI3K mice.
n = 8 per group.
(B) mRNA levels in hearts from dnPI3K mice.
n = 12 per group.
(C) mRNA levels in hearts from exercise-
trained WT, sedentary dnPI3K, and exercise-
trained dnPI3K mice versus sedentary WT.
n = 4–6 per group.
(D) Western analysis for PGC-1a in nuclear-
enriched fractions from caPI3K, dnPI3K, exer-
cise-trained WT, and control hearts. PGC-1a
expression in brown adipose tissue (BAT)
from cold-exposed WT mice was used as an
antibody control. NS = nonspecific band for
loading control.
*p < 0.05, **p < 0.01 versus WT or WT sed.
PPARa, peroxisome proliferator-activated re-
ceptor a; PGC-1a and b, PPARg coactivators
1a and 1b; ERRa, estrogen-related receptor a.phosphorylation of their downstream targets FoxO3a and
MARKS, respectively (Figure 7G). We performed a dose ti-
tration of both PKCl/z and Akt inhibitors and found that
1.0 mM PKCl/z inhibitor (PKCl/z I) or 0.5 mM Akt inhibitor
(Akt I) in the presence of insulin/IGF reduced phosphoryla-
tion of downstream targets to the level of cells not ex-
posed to insulin/IGF (Figure 7G), while higher levels of in-
hibitors tended to decrease cell viability. We found
a strong correlation between total CS activity and cell
number in NRCM preparations (Figure S5A), and, at the
concentrations used, Akt I did not reduce IGF-1-mediated
activation of PKCl/z signaling, nor did PKCl/z I attenuate
IGF-1-mediated activation of Akt targets (Figure S5B). To-
tal CS activity was unchanged between NRCMs in serum-
free medium treated with or without 1.0 mM PKCl/z I or
0.5 mM Akt I, but the combination of both inhibitors
reduced CS activity (Figure 7H). Insulin/IGF-1 treatment
of NRCMs increased absolute levels of CS activity, and in-
hibition of Akt signaling did not prevent this increase in CS
activity (Figure 7H). Inhibition of PKCl/z in the presence of
insulin/IGF-1 stimulation significantly reduced total CS
activity compared to insulin/IGF-1 alone, and the combi-
nation of PKCl/z and Akt inhibitors did not reduce CS
below that of PKCl/z inhibition alone (Figure 7H).
DISCUSSION
In this study, we show that PI3K is a critical modulator of
mitochondrial FA metabolism in the heart and that this
metabolic regulation is independent of Akt. Constitutive
activation of PI3K in the heart is sufficient to increase FA
utilization and selectively upregulate mitochondrial oxida-300 Cell Metabolism 6, 294–306, October 2007 ª2007 Elseviertive capacity for FA substrates. Inhibition of PI3K prevents
the increase in FAO capacity that occurs in response
to physiological cardiac hypertrophy, despite increased
PGC-1a mRNA and protein levels. Downstream of PI3K,
disruption of Akt signaling did not prevent mitochondrial
adaptations to exercise or PI3K activation. Inhibition of
cardiac Akt signaling in the context of exercise training
or PI3K activation attenuates hypertrophy but does not
diminish mitochondrial respiration or FAO enzyme activity.
Conversely, constitutive activation of cardiac Akt results in
cardiac hypertrophy but impairs mitochondrial function,
thereby dissociating a conserved signal for cellular growth
from mitochondrial adaptations. Thus, the current study
identifies a necessary role for PI3K in coordinating myo-
cardial FAO capacity with physiological cardiac hyper-
trophy independently of PGC-1a expression. We also
demonstrate that the long-term metabolic and mitochon-
drial effects of PI3K can be dissociated from its down-
stream target Akt, thereby representing a novel paradigm
in long-term regulation of metabolism by PI3K signaling.
Previous studies have shown that inhibition of PI3K
blocks the heart’s ability to hypertrophy in response to
exercise training (McMullen et al., 2003). We show here
that PI3K inhibition in hearts of exercise-trained mice
also prevents the increase in mitochondrial FAO capacity
despite a significant increase in PGC-1a expression. The
requirement of p110a in the regulation of cardiac growth
and the associated metabolic adaptation implies a tight
link between physiological hypertrophy and enhanced
mitochondrial FAO capacity. Activation of PI3K therefore
leads to a balanced increase in oxidative energy produc-
tion and cardiac growth that may protect against theInc.
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PI3K and Mitochondria in Cardiac HypertrophyFigure 6. Effect of Increased Akt Activa-
tion or Loss of Akt Function on Mito-
chondrial Adaptations to Hypertrophy
(A and B) Mitochondrial respiration (A) and ATP
production (B) with PC in cardiac fibers from
5- to 7-week-old caAkt and WT control mice.
(C and D) HADH (C) and CS (D) activity in whole
heart homogenates.
(E) CS activity in isolated mitochondria.
(F) Western analysis for phosphorylation of Akt
(Ser473) in hearts from sedentary (Sed) and
exercise-trained (Ex) Akt1/, Akt2/, kdAkt,
and control mice. Densitometric ratio of phos-
pho-Akt to total Akt (phospho/total) is shown
under each sample.
(G–I) Mitochondrial respiration with PC in car-
diac fibers (G), heart weight to tibia length
(HW/TL) ratio (H), and CS activity in skeletal
muscle (I) from sedentary and exercise-trained
Akt1/, Akt2/, kdAkt, and control mice.
n = 4–6 per group; *p < 0.05, **p < 0.01 versus
WT; yp < 0.05 versus sedentary control.progression to heart failure seen in pathological hypertro-
phy. This protective effect may be specific to the growth
factor- and exercise training-responsive class IA PI3Ks.
Indeed, previous studies have shown that whereas class
IA PI3Ks regulate hypertrophy, class IB PI3Ks modulate
contractility in the heart (Crackower et al., 2002).
Acute activation of PI3K in the heart, as occurs with
insulin stimulation, alters substrate utilization by increas-
ing glucose utilization and reducing FA oxidation (Belke
et al., 2002). PI3K is necessary for insulin-mediated glu-
cose uptake and thereby plays a primary role in acutely
increasing glucose utilization and reciprocally decreasing
FA oxidation in response to insulin (Pessin and Saltiel,
2000). Decreased FA utilization induced by insulin stimula-
tion seems at odds with our observation that increased
PI3K activation and increased FA oxidation are associated
with exercise-induced or physiological cardiac hypertro-
phy (Burelle et al., 2004; Luo et al., 2005; McMullen
et al., 2003). The current study distinguishes between
acute and chronic PI3K signaling and confirms the role
of chronic PI3K signaling in increasing mitochondrial
FAO capacity during physiological cardiac hypertrophy.
Thus, while acute activation of PI3K by insulin stimulationCell Mincreases glucose utilization and suppresses FA oxidation
in the heart, chronic activation of PI3K in the heart en-
hances FA oxidation by increasing mitochondrial oxidative
capacity for FA substrates.
Quantification of mRNA levels of FA oxidation enzymes
revealed divergent downstream effects of PI3K signaling
in the heart. Thus, activation of PI3K enhances FAO capa-
city in the absence of an increase in transcript levels of
FAO enzymes, with the exception of MCAD, thereby
suggesting that activation of PI3K in response to physio-
logic stimuli may enhance mitochondrial function via post-
transcriptional mechanisms. In contrast, inhibition of PI3K
is associated with decreased mRNA levels of FAO en-
zymes and prevents their increase in response to exercise
training. This suggested that PI3K signaling might modu-
late expression or activity of the transcriptional regulators
of FAO gene expression. However, dnPI3K hearts showed
no changes in mRNA levels of PPARa, PGC-1b, or ERRa,
which are transcriptional regulators of enzymes and
subunits in FAO and OXPHOS pathways in the heart
(Huss and Kelly, 2004). Indeed, despite diminished mito-
chondrial FAO capacity in hearts from exercise-trained
and sedentary dnPI3K mice, we observed increases inetabolism 6, 294–306, October 2007 ª2007 Elsevier Inc. 301
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Not Prevent PI3K-Mediated Mitochon-
drial Adaptations
(A) Heart weight to body weight ratio of double-
transgenic (DTG) and control mice. n = 12–20
per group.
(B) Phosphorylation of PI3K and Akt targets.
(C and D) State 3 of mitochondrial respiration
(C) and ATP production (D) with PC in cardiac
fibers. n = 5–9 per group.
(E and F) HADH (E) and CS (F) activity in whole
heart homogenates. n = 5–9 per group.
(G) Phosphorylation of Akt and PKCl/z targets
in neonatal rat cardiomyocytes (NRCMs) in the
presence or absence of insulin (100nM)/IGF-1
(10nM) and Akt inhibitor (Akt I) or PKCl/z inhib-
itor (PKCl/z I). Loading control for p-MARKS is
Ponceau-stained membrane.
(H) Total CS activity in NRCMs treated with
growth factor-free (GF free) medium or insu-
lin/IGF-1 medium plus Akt or PKCl/z inhibitors.
*p < 0.05, **p < 0.01 versus WT; zp < 0.05 ver-
sus caPI3K; xp < 0.01 versus GF free control;
yp < 0.05 versus all other groups (GF free) or
versus no inhibitor or Akt I following insulin/
IGF-1.PGC-1a mRNA and protein levels to a degree similar to
that observed in exercise-trained WT hearts. Thus, down-
regulation of FAO gene expression in dnPI3K hearts cannot
be accounted for by reduced expression of the transcrip-
tional regulators of FAO enzymes. However, the possibility
of changes in the activity of PPAR transcription factors or
PGC-1 transcriptional coactivators cannot be ruled out.
While diminished activity of transcriptional coactivators
may account for the downregulation of FAO transcript
levels in the heart when PI3K is inhibited, the lack of a sig-
nificant increase in mitochondrial FAO genes in caPI3K
hearts would argue against a change in the activity of tran-
scriptional regulators of mitochondrial FAO capacity when
PI3K is chronically activated in the heart.
Our results show that exercise training synergistically
increases mitochondrial FAO, PGC-1a expression, and
expression of mitochondrial genes, yet chronic activation
of PI3K in the heart does not recapitulate this transcrip-
tional profile. The differences in these two models may
be a consequence of the duration of PI3K activation. Inter-
mittent activation of PI3K, as occurs in exercise training,
may be more beneficial for mitochondrial function and is
a potential reason why exercise-trained hearts and hearts302 Cell Metabolism 6, 294–306, October 2007 ª2007 Elsevier Iwith constitutive activation of PI3K differ in the expression
of mitochondrial enzymes and their transcriptional regula-
tors. Indeed, we have evidence that models of chronic Akt
activation in the heart show diminished mitochondrial
function and decreased expression of PGC-1a and its
target genes (unpublished data). Thus, it appears that in-
termittent activation of PI3K during exercise training is
necessary for coordinated increases in mitochondrial en-
zyme gene expression and FAO capacity but that consti-
tutive activation of PI3K signaling leads to sustained Akt
activation, which can suppress the increased expression
of PGC-1a and its target mitochondrial FAO enzymes in
the heart. Nevertheless, our data strongly suggest that
sustained PI3K activation might be sufficient to promote
increased mitochondrial FAO independently of a coordi-
nate increase in PGC-1a-mediated transcriptional upreg-
ulation.
Our initial efforts to determine whether Akt mediates the
mitochondrial adaptations in response to PI3K signaling
revealed that constitutive activation of Akt in the heart
leads to diminished mitochondrial FAO capacity. This
result might not be surprising in light of data from many
groups showing that chronic Akt activation in the heart isnc.
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O’Neill and Abel, 2005; Shiojima et al., 2005). In addition,
hearts from mice with germline deletion of Akt1 and Akt2
and from mice with reduced Akt signaling via overexpres-
sion of a kinase-dead Akt1 isoform respond normally by
increasing mitochondrial function in response to exercise
training. These observations led us to hypothesize that the
modulation of mitochondrial function by PI3K is indepen-
dent of Akt signaling. We confirmed the findings previ-
ously reported by Shioi and colleagues (2002) that car-
diac-restricted expression of a kinase-dead Akt1 mutant
diminishes signaling downstream of Akt in the heart and
attenuates cardiac hypertrophy in caPI3K mice. We fur-
ther show that inhibition of Akt signaling does not prevent
the PI3K-mediated increase in mitochondrial FAO capac-
ity. Additionally, in contrast to dnPI3K hearts, in which ATP
synthesis was reduced with PC, attenuation of Akt signal-
ing in kdAkt (Shioi et al., 2002) and DTG hearts (Figure 7)
increased ATP production, further supporting the hypoth-
esis that mitochondrial remodeling in response to PI3K
signaling is distinct from the mitochondrial effects of Akt
signaling in the heart.
Our experiments in NRCMs identify a potential Akt-
independent target that may mediate the PI3K-dependent
metabolic effects on cardiomyocytes. PKCl/z was an
attractive target from a metabolic standpoint, as atypical
PKC isoforms have been shown to play a role in GLUT4
translocation in muscle (Bandyopadhyay et al., 2000;
Etgen et al., 1999) and have distinct effects from Akt on
lipid metabolism in the liver (Matsumoto et al., 2003; Tani-
guchi et al., 2006). In our NRCM experiments, we found
a strong correlation between CS activity and cell number.
These results indicate that in neonatal myocytes, growth
factor signaling promotes a proliferative response that
occurs in concert with a coordinate increase in mitochon-
drial content, whereas in the intact heart, a coordinated
increase in mitochondrial function accompanies myo-
cyte hypertrophy. We defined conditions in which growth
factor stimulation coordinately increased CS activity and
cellular hyperplasia despite inhibition of Akt activation.
By contrast, inhibition of growth factor activation of
PKCl/z signaling led to a significant decrease in mito-
chondrial CS activity in the absence of any change in
cellular viability. At the concentrations used, these inhibi-
tors were relatively specific for their respective substrates,
although we cannot completely rule out off-target effects.
Nevertheless, these observations raise the possibility that
PKCl/z signaling may be one potential PIP3/PDK1 down-
stream signal that is required for PI3K-dependent mito-
chondrial remodeling and provide preliminary evidence
that alternative PI3K targets can influence mitochondrial
function in response to growth factor stimulation. These
data do not rule out possible roles for other PIP3 targets,
such as serum- and glucocorticoid-regulated kinase
(SGK); p90 ribosomal S6 kinase (RSK); p21-activated
kinase 1 (PAK1); Rac, which can modulate actin remodel-
ing (Han et al., 1998); or PLCg, which activates pathways
downstream of IP3 and DAG (Xie et al., 2005). PI3K signif-
icantly affects a broad range of cellular signaling pathwaysCellin cardiac muscle, and more work will be needed to estab-
lish all of the Akt-independent but PIP3-dependent signal-
ing molecules that are required for regulation of mitochon-
drial remodeling in response to PI3K activation.
In summary, the current study identifies a central role for
PI3K in coordinating physiological cardiac growth and
metabolic capacity in the heart. Inhibition of PI3K is suffi-
cient to prevent the mitochondrial adaptations to exer-
cise-induced hypertrophy, despite increases in PGC-1a
mRNA and protein levels, indicating that upregulation of
PGC-1a expression and PI3K activation may function in
parallel to increase myocardial mitochondrial oxidative
capacity during physiological cardiac growth. Addition-
ally, whereas previous studies have identified an obligate
requirement of PI3K activation of Akt1 as a key regulator
of physiological cardiac cellular growth (DeBosch et al.,
2006; McMullen et al., 2003), we show here that PI3K likely
activates Akt-independent signaling pathways to mediate
the metabolic and mitochondrial adaptation that accom-
panies physiological cardiac hypertrophy.
EXPERIMENTAL PROCEDURES
Generation of Animals
Mice with cardiac-restricted expression of a dominant-negative p110a
(dnPI3K); the inter-SH2 fusion of p110a, which maintains PI3K in a con-
stitutively active state (caPI3K); a kinase-deficient (K197M) mutant
Akt1 (kdAkt); or a constitutively active (T308D/S473D) mutant Akt1
(caAkt) were generated in the Izumo laboratory and have been de-
scribed previously (Shioi et al., 2000, 2002). Germline Akt1 and Akt2
null mice were generated in the Birnbaum laboratory and have been
described previously (Cho et al., 2001a, 2001b). The animals were
fed standard chow and housed in temperature-controlled facilities
with a 12 hr light/12 hr dark cycle (lights on at 6:00 a.m.). All animal
experimentats were conducted in accordance with guidelines
approved by the Institutional Animal Care and Use Committee of the
University of Utah.
Swimming Exercise Training
Eight- to ten-week-old dnPI3K and control mice were subjected to
swimming exercise training as described previously (Wilkins et al.,
2004). Briefly, each day consisted of two bouts of swimming, sepa-
rated by 4 hr, beginning with a 10 min duration on the first day. The
two bouts of swimming were increased by 10 min each day until two
bouts of 90 min were achieved. Mice were trained for 13 additional
days (21 days total) and were sacrificed 18 hr after the last swim.
Substrate Metabolism in Isolated Working Hearts
Palmitate and glucose oxidation were measured in isolated working
hearts as described previously (Mazumder et al., 2004). Hearts were
perfused with 0.4 mM palmitate and 5 mM glucose without insulin.
Mitochondrial Respiration in Permeabilized Cardiac Fibers
Mitochondrial oxygen consumption and ATP production were mea-
sured in permeabilized cardiac fibers from 5- to 7-week-old mice of
each model using techniques described previously (Boudina et al.,
2007).
Enzyme Activity Assays
Mitochondrial Isolation
Mitochondria were isolated from fresh heart tissue by differential
centrifugation as described (Brand et al., 2005). Mitochondria were
resuspended in STE buffer and protein was quantified using Micro
BCA kit (Pierce) with BSA as a standard.Metabolism 6, 294–306, October 2007 ª2007 Elsevier Inc. 303
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CS activity was determined spectrophotometrically using whole heart
or mixed gastrocnemius muscle homogenates as described previ-
ously (Boudina et al., 2005; Clark and Rodnick, 1998; Rodnick and
Sidell, 1997). CS activity was also measured using 10 mg of isolated
mitochondrial protein and 10 ml of NRCM extracts.
3-Hydroxyacyl-CoA Dehydrogenase
HADH was determined spectrophotometrically using whole heart
homogenates as described previously (Boudina et al., 2005; Clark
and Rodnick, 1998).
Mitochondrial DNA Content
Mitochondrial DNA content was determined by quantitative real-time
polymerase chain reaction (qPCR). Briefly, total DNA was extracted
and purified from heart tissue with a DNeasy Kit (QIAGEN). Four nano-
grams of DNA was used to quantify mitochondrial and nuclear DNA
markers. qPCR was performed using an ABI Prism 7900HT instrument
(Applied Biosystems) in 384-well plate format with SYBR green I chem-
istry and ROX internal reference (Invitrogen). Analysis of results was
automated using scripting with SDS 2.1 (Applied Biosystems), Micro-
soft Access, and Microsoft Excel. b-actin was used as a nuclear DNA
marker.
Electron Microscopy
Electron microscopy samples were prepared and processed at the
Electron Microscopy Core Facility at the University of Utah. Briefly,
small pieces of endocardial and subendocardial tissue from the left
ventricle were fixed in 2.5% glutaraldehyde and 1% paraformaldehyde
in 0.1 M sodium cacodylate with 2.4% sucrose and 8 mM CaCl2 (pH
7.4) for at least 1 day. Samples were postfixed in 2% osmium tetroxide
in 0.1 M sodium cacodylate, stained en bloc with aqueous uranyl
acetate, and dehydrated through a graded series of ethanol washes
(50% up to 100%). Fixed samples were then infiltrated and embedded
in Spurr’s plastic and processed for electron microscopy. Mito-
chondrial morphology was assessed at 3,5003, 18,0003, and
70,0003 magnifications, and mitochondrial number was determined
in 16 pictures per group (n = 4 hearts and 4 pictures per heart) at
18,0003 magnification.
Gene Expression
mRNA was quantified by real-time polymerase chain reaction using an
ABI Prism 7900HT instrument in 384-well plate format as described
previously (Boudina et al., 2007). Cyclophilin (CPHN) was used as
a template normalizer in caPI3K studies. Because CPHN levels were
significantly increased in dnPI3K samples, vascular endothelial growth
factor A (VEGF), which was unchanged between groups, was used as
a template normalizer for dnPI3K studies. Primer sequences are listed
in Table S3.
Western Blot Analysis
PI3K/Akt Signaling Targets
Total proteins were extracted from frozen hearts as described pre-
viously (Boudina et al., 2005). Proteins were resolved by SDS-
PAGE and electrotransferred onto PVDF membranes (Millipore). The
following antibodies were used: phospho-Akt(Thr308), phospho-
Akt(Ser473), Akt, phospho-p70 S6 kinase(Thr389), p70 S6 kinase,
phospho-S6, S6, phospho-FoxO1(Thr24)/phospho-FoxO3a(Thr32),
FoxO1, phospho-GSK-3b, p-MARKS (Cell Signaling Technology),
FoxO3a (Upstate), and GSK-3b (Santa Cruz Biotechnology). Protein
detection was carried out with the appropriate horseradish peroxi-
dase-conjugated secondary antibody and ECL or ECL Plus detection
systems (Amersham Biosciences).
PGC-1a Western Analysis
For PGC-1a, nuclear-enriched fractions were isolated from cardiac
tissue using NE-PER nuclear and cytoplasmic extraction reagents
(Pierce Biotechnology). The polyclonal antibody for PGC-1a was gen-
erated in the Birnbaum laboratory.304 Cell Metabolism 6, 294–306, October 2007 ª2007 ElsevierPrimary Cell Culture
Primary NRCMs were harvested using a modified protocol (Chien
et al., 1985; Sen et al., 1988). Following mechanical and enzymatic
(collagenase/pancreatin) separation of 1- to 3-day-old rat pup hearts,
Percoll gradient-purified cardiomyocytes were plated on gelatin-
coated plates at a density of 160,000/cm2 in 10% horse serum, 5%
fetal bovine serum, and 100 nM BrdU containing DMEM/M199 me-
dium (Invitrogen). Following 24 hr recovery, medium was replaced
with serum and growth factor-free medium, and treatments were
started. Cells were treated with or without 100 nM insulin, 10 nM
IGF-1 (National Hormone and Peptide Program), and the indicated
concentrations of Akt (Calbiochem, #124008) and PKCl/z (Biosource)
inhibitors for 72 hr. Media and treatments were refreshed every 24 hr.
Following treatment, cells were harvested and counted for CS activity
assay or Western blot analysis.
Statistical Analyses
Data are expressed as mean ± SEM. An unpaired Student’s t test was
used to analyze data sets with two groups. All other differences were
analyzed by ANOVA, and significance was assessed by Fisher’s
protected least significant difference test. For all analyses, p < 0.05
was accepted as indicating a significant difference. Statistical calcula-
tions were performed using the StatView 5.0.1 software package (SAS
Institute).
Supplemental Data
Supplemental Data include three tables and five figures and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/6/4/294/DC1/.
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